{"id":"tramadol-hcl-contramid-once-a-day","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Dizziness"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Somnolence"},{"rate":"5-10%","effect":"Constipation"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Insomnia"},{"rate":"5-10%","effect":"Dry mouth"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This binding action results in the inhibition of pain signal transmission from the brain to the body, providing analgesic effects. Tramadol HCl also has a weak serotonin-norepinephrine reuptake inhibition (SNRI) component, which contributes to its analgesic effects.","oneSentence":"Tramadol HCl is a centrally acting opioid analgesic that works by binding to mu-opioid receptors in the brain.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:39:48.951Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to moderately severe pain"},{"name":"Severe pain"}]},"trialDetails":[{"nctId":"NCT00833911","phase":"PHASE3","title":"An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2003-04","conditions":"Osteoarthritis, Knee","enrollment":392},{"nctId":"NCT00950651","phase":"PHASE3","title":"A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol HCl / Contramid® Tablets to Twice Daily Tramadol HCl (SR) for the Treatment of Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2002-03","conditions":"Osteoarthritis, Knee, Pain","enrollment":431}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Tramadol HCl Contramid® Once A Day","genericName":"Tramadol HCl Contramid® Once A Day","companyName":"Labopharm Inc.","companyId":"labopharm-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tramadol HCl is a centrally acting opioid analgesic that works by binding to mu-opioid receptors in the brain. Used for Moderate to moderately severe pain, Severe pain.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}